ATC code B02

ATC codes
B Blood and blood forming organs
B01 Antithrombotic agents
B02 Antihemorrhagics
B03 Antianemic preparations
B05 Blood substitutes and perfusion solutions
B06 Other hematological agents
A B C D G H QI J L M N P R S V (Hover over links to see titles)

ATC code B02 Antihemorrhagics is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.<ref>

ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis(link). {{{website}}}. National Institutes of Health.

</ref><ref>

ATC-Klassifikation mit definierten Tagesdosen DDD(link). {{{website}}}. German Institute for Medical Documentation and Information.

</ref> Subgroup B02 is part of the anatomical group B Blood and blood forming organs.<ref>

ATC/DDD Index 2022

code B02(link).

{{{website}}}. WHO Collaborating Centre for Drug Statistics Methodology.

</ref>

Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QB02.<ref>

ATCvet Index 2022

code QB02(link).

{{{website}}}. WHO Collaborating Centre for Drug Statistics Methodology.

</ref>

National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.

B02A Antifibrinolytics

B02AA Amino acids

B02AA01 Aminocaproic acid

B02AA02 Tranexamic acid

B02AA03 Aminomethylbenzoic acid

B02AB Proteinase inhibitors

B02AB01 Aprotinin

B02AB02 Alfa1 antitrypsin

B02AB04 Camostat

B02B Vitamin K and other hemostatics

B02BA Vitamin K

B02BA01 Phytomenadione

B02BA02 Menadione

B02BB Fibrinogen

B02BB01 Human fibrinogen

B02BC Local hemostatics

B02BC01 Absorbable gelatin sponge

B02BC02 Oxidized cellulose

B02BC03 Tetragalacturonic acid hydroxymethylester

B02BC05 Adrenalone

B02BC06 Thrombin

B02BC07 Collagen

B02BC08 Calcium alginate

B02BC09 Epinephrine

B02BC30 Combinations

B02BD Blood coagulation factors

B02BD01 Coagulation factor IX, II, VII and X in combination (Prothrombin complex concentrate)

B02BD02 Coagulation factor VIII

B02BD03 Factor VIII inhibitor bypassing activity

B02BD04 Coagulation factor IX

B02BD05 Coagulation factor VII

B02BD06 von Willebrand factor and coagulation factor VIII in combination

B02BD07 Coagulation factor XIII

B02BD08 Coagulation factor VIIa

B02BD10 von Willebrand factor

B02BD11 Catridecacog

B02BD13 Coagulation factor X

B02BD14 Susoctocog alfa

B02BD30 Thrombin

B02BX Other systemic hemostatics

B02BX01 Etamsylate

B02BX02 Carbazochrome

B02BX03 Batroxobin

B02BX04 Romiplostim

B02BX05 Eltrombopag

B02BX06 Emicizumab

B02BX07 Lusutrombopag

B02BX08 Avatrombopag

B02BX09 Fostamatinib